Data on file, Amgen; [Aranesp®
(darbepoetin alfa) Periodic Benefit-Risk Evaluation Report; December 21, 2016]. 2.
Data on file, Amgen; [Patient Years; December 2017]. 3.
Vanrenterghem Y, Bárány P, Mann JFE, et al. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int
. 2002;62(6):2167-2175. 4.
Data on file, Amgen; [Historic Aranesp®
Shipment Summary; April 27, 2017]. 5.
Data on file, Amgen; 2018.